Socioeconomic efficiency of neonatal screening for spinal muscular atrophy in the Russian Federation

Socioeconomic efficiency of neonatal screening for spinal muscular atrophy in the Russian Federation

Background. Spinal muscular atrophy (SMA) is a severe rare disease that has been widely discussed in recent years. Achievements in etiopathogenetic therapy and the social significance of the disease (child population, high mortality), the cost of treatment attracted the attention of the public and t...

Full description

Saved in:
Bibliographic Details
Main Authors: I. A. Komarov, A. R. Malakhova, T. P. Vasilyeva, E. Yu. Shukan, O. Yu. Aleksandrova, R. A. Zinchenko, A. V. Polyakov, S. S. Nikitin, E. Yu. Sapego, S. I. Kutsev
Format: Article
Language:Russian
Published: ABV-press 2023-10-01
Series:Нервно-мышечные болезни
Subjects:
spinal muscular atrophy
newborn screening
cost analysis
rare diseases
orphan drugs
drug coverage
health care
funding
budget
Online Access:https://nmb.abvpress.ru/jour/article/view/556
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items